David Lamb - Nuveen Preferred Chief Administrative Officer
| JPI Etf | USD 20.56 0.30 1.48% |
| Age | 57 |
| Tenure | 9 years |
| Phone | 312 917 7700 |
| Web | https://www.nuveen.com/CEF/Product/Overview.aspx?fundcode=JPI |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Salvatore Schiavone | John Hancock Preferred | 55 | |
| Frank Gentile | Tekla Healthcare Investors | 62 | |
| William Reardon | Tekla Life Sciences | 74 | |
| Lisa Phelan | Cohen And Steers | 51 | |
| Lucinda Stebbins | Tekla Life Sciences | 73 | |
| Gregory Russo | John Hancock Preferred | 71 | |
| Grace Fey | John Hancock Preferred | 74 | |
| Deborah Jackson | John Hancock Preferred | 68 | |
| Peter Branner | Tekla Life Sciences | 60 | |
| William Reardon | Tekla Healthcare Investors | 74 | |
| Thomas Kent | Tekla Healthcare Investors | 67 | |
| James Boyle | John Hancock Preferred | 61 | |
| Dr MS | Tekla Healthcare Investors | 71 | |
| Charles Bardelis | John Hancock Preferred | 79 | |
| Rakesh Jain | Tekla Healthcare Investors | 69 | |
| Linda Puchalski | Flaherty Crumrine Preferredome | 63 | |
| Peter Burgess | John Hancock Preferred | 78 | |
| Laura Woodward | Tekla Healthcare Investors | 51 | |
| Laurie Lodolo | Flaherty Crumrine Preferred | 56 | |
| Roger Ko | Flaherty Crumrine Preferredome | 45 | |
| Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
Nuveen Preferred Money Managers
| Mark Winget, Vice President Assistant Secretary | ||
| Robert Young, Independent Trustee | ||
| E Wickerham, Vice President Controller | ||
| Deann Morgan, Vice President | ||
| Jack Evans, Independent Trustee | ||
| David Lamb, Chief Administrative Officer | ||
| Mark Czarniecki, Vice President Assistant Secretary | ||
| Cedric Antosiewicz, Chief Administrative Officer | ||
| Judith Stockdale, Independent Trustee | ||
| William Siffermann, Vice President | ||
| William Meyers, Vice President | ||
| Michael Perry, Vice President | ||
| Jacques Longerstaey, Vice President | ||
| Matthew Thornton, Independent Trustee | ||
| Margaret Wolff, Independent Trustee | ||
| Brian Lockhart, Vice President | ||
| Diana Gonzalez, Vice President Assistant Secretary | ||
| Gifford Zimmerman, Chief Compliance Officer, Vice President | ||
| Nathaniel Jones, Vice President Treasurer | ||
| Terence Toth, Independent Chairman of the Board of Trustees | ||
| Carole Stone, Independent Trustee | ||
| Jon Meissner, Vice President, Assistant Secretary | ||
| Christopher Rohrbacher, Vice President Assistant Secretary | ||
| Walter Kelly, Vice President Chief Compliance Officer | ||
| John Nelson, Independent Trustee | ||
| Albin Moschner, Independent Trustee | ||
| Kevin McCarthy, Vice President, Assistant Secretary | ||
| William Hunter, Independent Trustee | ||
| Tina Lazar, Vice President |
Nuveen Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Nuveen Preferred a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 22.77 M | ||||
| Shares Owned By Institutions | 15.98 % | ||||
| Number Of Shares Shorted | 18.64 K | ||||
| Price To Earning | 14.90 X | ||||
| Short Ratio | 0.45 X | ||||
| Earnings Per Share | 1.28 X | ||||
| Number Of Employees | 21 | ||||
| Beta | 0.48 | ||||
| Market Capitalization | 487.33 M | ||||
| Annual Yield | 0.01 % |
Currently Active Assets on Macroaxis
When determining whether Nuveen Preferred offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nuveen Preferred's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nuveen Preferred And Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Nuveen Preferred And Etf:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Nuveen Preferred and. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
The market value of Nuveen Preferred is measured differently than its book value, which is the value of Nuveen that is recorded on the company's balance sheet. Investors also form their own opinion of Nuveen Preferred's value that differs from its market value or its book value, called intrinsic value, which is Nuveen Preferred's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuveen Preferred's market value can be influenced by many factors that don't directly affect Nuveen Preferred's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuveen Preferred's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuveen Preferred is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuveen Preferred's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.